{"altmetric_id":2190662,"counts":{"readers":{"mendeley":23,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["BTumour_fighter"],"posts_count":1}},"citation":{"abstract":"Both the epidermal growth factor receptor and vascular endothelial growth factor pathways are frequently overexpressed in glioblastoma multiforme. This study combined bevacizumab, a vascular endothelial growth factor inhibitor, and erlotinib, an epidermal growth factor receptor inhibitor, with standard radiation and temozolomide (TMZ), with the goal of improving overall survival (OS).","abstract_source":"pubmed","altmetric_jid":"4f6fa62f3cf058f61000828a","authors":["Jennifer L. Clarke","Annette M. Molinaro","Joanna J. Phillips","Nicholas A. Butowski","Susan M. Chang","Arie Perry","Joseph F. Costello","Ashley A. DeSilva","Jane E. Rabbitt","Michael D. Prados"],"doi":"10.1093\/neuonc\/nou029","first_seen_on":"2014-03-17T15:21:33+00:00","issns":["1523-5866"],"journal":"Neuro-Oncology","last_mentioned_on":1395069648,"links":["http:\/\/neuro-oncology.oxfordjournals.org\/content\/early\/2014\/03\/15\/neuonc.nou029.short?rss=1"],"pdf_url":"http:\/\/neuro-oncology.oxfordjournals.org\/content\/early\/2014\/03\/15\/neuonc.nou029.full.pdf","pmid":"24637230","publisher":"Oxford University Press","publisher_subjects":[{"name":"Neurosciences","scheme":"era"},{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms","neurology"],"title":"A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/singleinstitution-phase-ii-trial-radiation-temozolomide-erlotinib-bevacizumab-initial-treatment-glio"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4506837,"mean":5.127001515923,"rank":3102280,"this_scored_higher_than_pct":21,"this_scored_higher_than":972582,"rank_type":"exact","sample_size":4506837,"percentile":21},"similar_age_3m":{"total_number_of_other_articles":111851,"mean":7.9472466160037,"rank":77462,"this_scored_higher_than_pct":21,"this_scored_higher_than":24179,"rank_type":"exact","sample_size":111851,"percentile":21},"this_journal":{"total_number_of_other_articles":978,"mean":2.4000696008188,"rank":734,"this_scored_higher_than_pct":12,"this_scored_higher_than":118,"rank_type":"exact","sample_size":978,"percentile":12},"similar_age_this_journal_3m":{"total_number_of_other_articles":10,"mean":3.1944444444444,"rank":10,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":10,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":1,"Researcher":5,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":5,"Student  > Master":5,"Other":1,"Student  > Bachelor":2,"Professor":1,"Student  > Postgraduate":1},"by_discipline":{"Medicine and Dentistry":15,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":2,"Mathematics":2,"Unspecified":1}}},"geo":{"mendeley":{"DK":1,"IN":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/BTumour_fighter\/status\/445580517748920320","license":"public","citation_ids":[2190662],"posted_on":"2014-03-17T15:20:48+00:00","author":{"name":"Ale C.","image":"https:\/\/pbs.twimg.com\/profile_images\/456317179055460352\/ZeLNx979_normal.jpeg","description":"Dx: Astrocytoma grade II (1997). After 17 years I'm still here, fighting my disease like the very 1st day. Sharing info about #BrainTumour . Welcome! :)","id_on_source":"BTumour_fighter","tweeter_id":"377932657","geo":{"lt":null,"ln":null},"followers":537},"tweet_id":"445580517748920320"}]}}